Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

High-definition Transcranial Direct Current Stimulation (HD-tDCS) Verbal Learning

This study is currently recruiting participants. (see Contacts and Locations)
Verified August 2014 by The University of New South Wales
Sponsor:
Information provided by (Responsible Party):
Melissa Pigot, The University of New South Wales
ClinicalTrials.gov Identifier:
NCT01733576
First received: November 26, 2012
Last updated: August 11, 2014
Last verified: August 2014

November 26, 2012
August 11, 2014
Not Provided
March 2014   (final data collection date for primary outcome measure)
Ray Auditory Verbal Learning Test (RAVLT) [ Designated as safety issue: No ]
Same as current
Complete list of historical versions of study NCT01733576 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
High-definition Transcranial Direct Current Stimulation (HD-tDCS) Verbal Learning
Enhancing Verbal Learning and Memory Using High-Definition Transcranial Direct Current Stimulation (HD-tDCS)

This project will use a new form of non-invasive brain stimulation called high-definition transcranial direct current stimulation (HD-tDCS) to facilitate verbal learning. This form of stimulation is similar to transcranial direct current stimulation (tDCS) but allows for more spatially focused stimulation. We hypothesise that HD-tDCS when applied to regions of the brain important for learning and memory will improve verbal learning and memory compared to sham HD-tDCS.

Not Provided
Interventional
Phase 0
Allocation: Randomized
Intervention Model: Crossover Assignment
Masking: Single Blind (Subject)
Primary Purpose: Basic Science
Verbal Learning and Memory
Device: HD-tDCS
  • Sham Comparator: Sham HD-tDCS
    Intervention: Device: HD-tDCS
  • Active Comparator: Active HD-tDCS 1
    Intervention: Device: HD-tDCS
  • Active Comparator: Active HD-tDCS 2
    Intervention: Device: HD-tDCS
  • Active Comparator: Active HD-tDCS 3
    Intervention: Device: HD-tDCS
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruiting
16
Not Provided
March 2014   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Ages 18 - 40 years
  • Right-handed

Exclusion Criteria:

  • concurrent medication likely to affect mental performance
  • current history of drug or alcohol abuse or dependence
  • any psychiatric or neurological disorder, recent head injury, or history of seizure or stroke.
Both
18 Years to 40 Years
Yes
Contact: Donel Martin, PhD 61 2 9382 9261 donel.martin@unsw.edu.au
Australia
 
NCT01733576
CB64
No
Melissa Pigot, The University of New South Wales
The University of New South Wales
Not Provided
Not Provided
The University of New South Wales
August 2014

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP